Results 1 to 10 of about 345,568 (268)

Annual dialysis data report 2022, Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry

open access: yesRenal Replacement Therapy
The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was sent to 4521 dialysis facilities at the end of 2022, among which 4464 facilities (98.7%) responded to the facility survey, and 4276 facilities (94.6%) responded
Norio Hanafusa   +14 more
doaj   +1 more source

Annual dialysis data report 2021, Japanese Society for Dialysis Therapy (JSDT) renal data registry

open access: yesRenal Replacement Therapy
The annual survey of the Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry (JRDR) at the end of 2021 was conducted at 4508 facilities, of which 4454 facilities (98.8%) returned the facility questionnaire and 4251 (94.3%) returned the ...
Norio Hanafusa   +15 more
doaj   +1 more source

Hydrothorax as a Complication of Peritoneal Dialysis: A Case Report

open access: yesCase Reports in Nephrology
Hydrothorax is a possible complication of peritoneal dialysis due to migration of dialysate from the peritoneal cavity to the thoracic cavity through a congenital or acquired diaphragmatic defect that allows its passage.
Luca Piscitani   +5 more
doaj   +1 more source

Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients

open access: yesRenal Replacement Therapy
Background Cinacalcet hydrochloride (cinacalcet), an oral calcimimetics for secondary hyperparathyroidism (SHPT), has been widely used worldwide. In contrast, evocalcet, an improved derivative of cinacalcet, was approved only in Japan in 2018 and has not
Nobuo Nagano   +9 more
doaj   +1 more source

Age-stratified association between hyperpolypharmacy (≥ 10 medications) and mortality in patients undergoing maintenance hemodialysis: a 3-year single-center study

open access: yesRenal Replacement Therapy
Background Patients undergoing maintenance hemodialysis frequently experience polypharmacy because of multiple comorbidities. Although polypharmacy has been linked to increased mortality in the general elderly population, its impact on survival may ...
Nobuo Nagano   +7 more
doaj   +1 more source

Serum magnesium and risk of arteriovenous fistula thrombosis in hemodialysis: a retrospective cohort study

open access: yesBMC Nephrology
Background Arteriovenous fistula (AVF) thrombosis is a major cause of vascular access failure in patients undergoing maintenance hemodialysis (HD). Although magnesium has established vascular protective properties, its relationship with AVF thrombosis ...
Natalia Stepanova   +8 more
doaj   +1 more source

Circulating Muscle Markers for Sarcopenia in Peritoneal Dialysis

open access: yesInternational Journal of Nephrology
Sarcopenia, characterized by the progressive decline in muscle mass and function, is an important complication among patients undergoing peritoneal dialysis (PD).
Lixing Xu   +5 more
doaj   +1 more source

POS-241 GLOMERULAR FILTRATION RATE AND FIRST NEPHROLOGY CONSULTATION IN THE ELDERLY

open access: yesKidney International Reports, 2021
Y. ELOUAER   +11 more
doaj   +1 more source

Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis. [PDF]

open access: yesDiabetes Care
Klein KR   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy